Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemias.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 7577621)

Published in Br J Haematol on September 01, 1995

Authors

T Nakamaki1, N Kawamata, J Schwaller, A Tobler, M Fey, S Pakkala, Y Y Lee, B K Kim, K Fukuchi, N Tsuruoka

Author Affiliations

1: Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine 90048, USA.

Articles citing this

The CDKN2A (p16) gene and human cancer. Mol Med (1997) 1.46

Articles by these authors

Features of promising technologies for pretreatment of lignocellulosic biomass. Bioresour Technol (2005) 7.22

Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Eur J Cancer (1998) 3.03

A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood (1999) 2.98

Coordinated development of leading biomass pretreatment technologies. Bioresour Technol (2005) 2.92

Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ (2001) 2.40

Interactions between endogenous gamma interferon and tumor necrosis factor in host resistance against primary and secondary Listeria monocytogenes infections. Infect Immun (1989) 2.28

Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe. Blood (1994) 2.24

Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test. Neurogastroenterol Motil (2015) 2.12

Rescue endoscopic bleeding control for nonvariceal upper gastrointestinal hemorrhage using clipping and detachable snaring. Endoscopy (2013) 2.07

Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Clin Cancer Res (2001) 2.07

Structure of Marek's disease virus DNA: detailed restriction enzyme map. J Virol (1984) 2.03

Bone marrow scintigraphy using technetium-99m-antigranulocyte antibody in hematologic disorders. J Nucl Med (1996) 2.01

MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition. Oncogene (2010) 1.99

p27/Kip1 mutation found in breast cancer. Cancer Res (1996) 1.94

Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. J Clin Oncol (2000) 1.92

Identifying breast cancer patients at high risk for bone metastases. J Clin Oncol (2000) 1.91

1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci U S A (1987) 1.89

Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia (2006) 1.77

Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII. J Clin Oncol (2003) 1.75

Comparative sugar recovery data from laboratory scale application of leading pretreatment technologies to corn stover. Bioresour Technol (2005) 1.67

Historical demography of Mullerian mimicry in the neotropical Heliconius butterflies. Proc Natl Acad Sci U S A (2004) 1.65

Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma. Aliment Pharmacol Ther (2012) 1.60

Process and technoeconomic analysis of leading pretreatment technologies for lignocellulosic ethanol production using switchgrass. Bioresour Technol (2011) 1.51

The structure of Marek disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA. Proc Natl Acad Sci U S A (1985) 1.50

Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer. J Clin Oncol (2001) 1.49

Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother Oncol (1991) 1.47

A new ray-tracing program RIGTRACE for X-ray optical systems. J Synchrotron Radiat (2001) 1.44

Human basophils express CD22 without expression of CD19. Cytometry (1999) 1.44

Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia. EMBO J (2000) 1.44

Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue? Head Neck (1998) 1.44

Primary angiosarcoma of the spleen. CT and MR imaging. Acta Radiol (1994) 1.43

Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood (1995) 1.42

Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation. Mol Cell Biol (2001) 1.41

Minimal access surgery in managing anterior lumbar disorders. Clin Orthop Relat Res (2001) 1.39

A novel mutation that leads to a congenital factor XI deficiency in a Japanese family. Am J Hematol (2000) 1.39

Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial. Br J Haematol (2000) 1.37

Gene involved in the 3q27 translocation associated with B-cell lymphoma, BCL5, encodes a Krüppel-like zinc-finger protein. Blood (1994) 1.36

Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol (2005) 1.36

Introduction of human gamma 1 immunoglobulin genes into fertilized mouse eggs. J Biochem (1984) 1.35

Induction of blood-brain barrier properties in immortalized bovine brain endothelial cells by astrocytic factors. Neurosci Res (1999) 1.34

Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res (2000) 1.34

High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses. Leukemia (2012) 1.33

Pretreatment of corn stover by aqueous ammonia. Bioresour Technol (2003) 1.32

Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol (2000) 1.32

Lymphoma of the head and neck. Radiol Clin North Am (1990) 1.31

Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group. Leukemia (2000) 1.31

Identification of stress-responsive genes in Streptococcus mutans by differential display reverse transcription-PCR. Infect Immun (2001) 1.30

SP-40,40 is a constituent of Alzheimer's amyloid. Acta Neuropathol (1992) 1.30

Dlk1 in normal and abnormal hematopoiesis. Leukemia (2005) 1.28

Transcriptional and posttranscriptional modulation of myeloid colony-stimulating factor expression by tumor necrosis factor and other agents. Mol Cell Biol (1988) 1.27

Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells. J Clin Invest (1995) 1.25

Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. Hum Pathol (2000) 1.24

Comparative sugar recovery and fermentation data following pretreatment of poplar wood by leading technologies. Biotechnol Prog (2009) 1.23

Purine nucleoside phosphorylase from human erythroyctes. II. Kinetic analysis and substrate-binding studies. J Biol Chem (1968) 1.22

TEL/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor. Blood (1999) 1.19

Measurement of the negative muon anomalous magnetic moment to 0.7 ppm. Phys Rev Lett (2004) 1.19

Purine nucleoside phosphorylase from human erythrocytes. I. Purification and properties. J Biol Chem (1968) 1.19

cDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human beta-amyloid precursor protein and its homologues with the mouse Fe65 protein. Hum Mol Genet (1996) 1.17

First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88. Ann Oncol (1996) 1.15

Malignant glomus tumor originating in the superior mediastinum--an immunohistochemical and ultrastructural study. J Korean Med Sci (1991) 1.14

Characterization of recombinant human adipocyte-derived leucine aminopeptidase expressed in Chinese hamster ovary cells. J Biochem (2000) 1.14

Endocytosis and shedding of the decay accelerating factor on human polymorphonuclear cells. J Immunol (1989) 1.13

Exploratory activity and spatial learning in 12-month-old APP(695)SWE/co+PS1/DeltaE9 mice with amyloid plaques. Neurosci Lett (2005) 1.13

Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. J Clin Oncol (2004) 1.13

Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience. Leukemia (2003) 1.13

Critical care in obstetrical patients: an eight-year review. Chin Med J (Engl) (1997) 1.13

The source of APRIL up-regulation in human solid tumor lesions. J Leukoc Biol (2006) 1.11

Differential diagnosis of intestinal Behçet's disease and Crohn's disease by colonoscopic findings. Endoscopy (2009) 1.11

Transcranial resection of tumors of the paranasal sinuses and nasal cavity. J Neurosurg (1989) 1.10

Constitutive mRNA and protein production of macrophage colony-stimulating factor but not of other cytokines by synovial fibroblasts from rheumatoid arthritis and osteoarthritis patients. Br J Rheumatol (1994) 1.10

Ommaya reservoirs in 387 cancer patients: a 15-year experience. Neurology (1985) 1.10

Epstein-Barr virus-associated anaplastic large cell lymphoma in renal transplant patients. Am J Clin Pathol (1992) 1.10

Homozygosity mapping of the Werner syndrome locus (WRN). Genomics (1994) 1.09

Sequence variation of a novel heptahelical leucocyte receptor through alternative transcript formation. Biochem J (1995) 1.09

miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme. Oncogene (2012) 1.08

The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo. Cancer Genet Cytogenet (2001) 1.08

Normal ventilatory movement of the right hemidiaphragm studied by ultrasonography and pneumotachography. Radiology (1983) 1.08

P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833. Blood (1999) 1.07

Granulocyte-macrophage colony-stimulating factor. Sensitive and receptor-mediated regulation by 1,25-dihydroxyvitamin D3 in normal human peripheral blood lymphocytes. J Clin Invest (1987) 1.07

Mutations of p53 and human papillomavirus infection in cervical carcinoma. Cancer (1993) 1.07

Molecular basis of clarithromycin-resistance in Mycobacterium avium intracellulare complex. Tuber Lung Dis (2000) 1.06

A macrolide-lincosamide-streptogramin B resistance determinant from Bacillus anthracis 590: cloning and expression of ermJ. J Gen Microbiol (1993) 1.06

Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1. Oncogene (2006) 1.06

Letter: inverse correlation between Helicobacter pylori and obesity - a conclusion too early? Aliment Pharmacol Ther (2014) 1.06

Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia. Leukemia (2010) 1.05

Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea. Leukemia (2003) 1.05

Ethanol fermentation of crude acid hydrolyzate of cellulose using high-level yeast inocula. Biotechnol Bioeng (1985) 1.04

Alterations of p16INK4A and p15INK4B genes in gastric carcinomas. Cancer (1997) 1.04

Cytotoxicity mediated by conditional expression of a carboxyl-terminal derivative of the beta-amyloid precursor protein. Brain Res Mol Brain Res (1994) 1.03

Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group. J Clin Oncol (2004) 1.03

Supratentorial ependymomas: computed tomographic and pathologic correlations. J Comput Tomogr (1986) 1.03

Comparative data on effects of leading pretreatments and enzyme loadings and formulations on sugar yields from different switchgrass sources. Bioresour Technol (2011) 1.03

Coagulopathy in hemorrhagic fever with renal syndrome (Korean hemorrhagic fever). Rev Infect Dis (1989) 1.03

Purine nucleoside phosphorylase from human erythrocytes. 3. Inhibition by the inosine analog formycin B of the isolated enzyme and of nucleoside metabolism in intact erythrocytes and sarcoma 180 cells. Mol Pharmacol (1968) 1.02

Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood (1995) 1.02

Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. Biochim Biophys Acta (1997) 1.02

Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG). Br J Cancer (2001) 1.02

Hybrid incompatibility is consistent with a hybrid origin of Heliconius heurippa Hewitson from its close relatives, Heliconius cydno Doubleday and Heliconius melpomene Linnaeus. J Evol Biol (2005) 1.01